This topic contains a solution. Click here to go to the answer

Author Question: A patient comes to the clinic and asks the primary care NP about using a newly developed formulation ... (Read 17 times)

lb_gilbert

  • Hero Member
  • *****
  • Posts: 588
A patient comes to the clinic and asks the primary care NP about using a newly developed formulation of the drug the patient has been taking for a year. When deciding whether or not to prescribe this formulation, the NP should:
 
  a. tell the patient that when postmarketing data is available, it will be considered.
  b. review the pharmaceutical company promotional materials about the new medication.
  c. prescribe the medication if it is less expensive than the current drug formulation.
  d. prescribe the medication if the new drug is available in an extended-release form.

Question 2

A patient who has been taking propranolol for 6 months reports having nocturnal cough and shortness of breath. The primary care NP should:
 
  a. tell the patient to stop taking the medication.
  b. obtain serum drug levels to monitor for toxicity of this medication.
  c. instruct the patient to increase activity and exercise to counter these side effects.
  d. contact the patient's cardiologist to discuss changing to a selective B-blocker.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

isabelt_18

  • Sr. Member
  • ****
  • Posts: 342
Answer to Question 1

A
About 6 to 12 months of postmarketing experience can yield information about drug efficacy and side effects, so patients should be cautioned to wait for these data. Drug company promotional materials have biased information. Most new drugs are more expensive, and costs alone should not determine drug choice. Extended-release forms are often more expensive.

Answer to Question 2

D
Nocturnal cough and shortness of breath may be a side effect of propranolol, which can cause bronchospasm because it is a nonselective -blocker. The NP should discuss a selective B-blocker with the patient's cardiologist. -Blockers should never be stopped abruptly. Bradycardia and hypotension are signs of toxicity. Increasing activity would not counter these side effects if bronchospasm is the cause.




lb_gilbert

  • Member
  • Posts: 588
Reply 2 on: Jul 24, 2018
Thanks for the timely response, appreciate it


rleezy04

  • Member
  • Posts: 322
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

The first war in which wide-scale use of anesthetics occurred was the Civil War, and 80% of all wounds were in the extremities.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

Calcitonin is a naturally occurring hormone. In women who are at least 5 years beyond menopause, it slows bone loss and increases spinal bone density.

Did you know?

It is important to read food labels and choose foods with low cholesterol and saturated trans fat. You should limit saturated fat to no higher than 6% of daily calories.

Did you know?

Human neurons are so small that they require a microscope in order to be seen. However, some neurons can be up to 3 feet long, such as those that extend from the spinal cord to the toes.

For a complete list of videos, visit our video library